The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The living-history museum in Fishers is making plans for a larger exhibit that is expected to open in 2029 and better tell ...

Purdue partners with Eli Lilly and Merck to launch the Young Institute Pharmaceutical Manufacturing Consortium, focusing on sterile injectables.

The U.S. Department of Labor is looking to phase out sheltered work programs that are allowed to pay disabled workers less ...

Butler University's plans to renovate and expand Clowes Memorial Hall, including the addition of a ballroom space, aim to ...

Eli Lilly has made a foray into the radiopharmaceuticals ... radiopharmaceutical manufacturing facility on Lilly’s campus in Indianapolis, clearing one of the key obstacles to entering the ...

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

Online master’s degrees in engineering and education from Purdue again rank among the nation’s finest. Four of Pur ...

With a market cap of $759.4 billion, Eli Lilly operates across diverse therapeutic areas, providing cutting-edge solutions in oncology, diabetes, immunology, and neuroscience. The Indianapolis ...

Eli Lilly said it received Food and Drug Administration ... is now approved to treat two types of inflammatory bowel disease in the U.S., the Indianapolis company said Wednesday.

Eli Lilly on Tuesday said the company’s revenue ... market growth was slower than the company anticipated. Shares of the Indianapolis-based company fell by as much as 8% in morning trading ...

Eli Lilly on Tuesday said the company’s revenue in 2024 totaled ... CEO David Ricks said GLP-1 market growth was slower than the company anticipated. Shares of the Indianapolis-based company fell by ...